T Castel

Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis.

Begoña Mellado, Dolors Colomer, T Castel et al. · Journal of Clinical Oncology · 1996 · 185 citations

Role of the <i>CDKN2A</i> Locus in Patients With Multiple Primary Melanomas

Susana Puig, Josep Malvehy, Célia Bádenas et al. · Journal of Clinical Oncology · 2005 · 145 citations

Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients.

Begoña Mellado, L. V. Gutierrez, T Castel et al. · PubMed · 1999 · 97 citations

Disease-free Melanoma Patients, Pathology, Prognostic Significance +17

Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene.

Susana Puig, Anna Ruiz, Conxi Lázaro et al. · PubMed · 1995 · 85 citations

S-100 Protein Serum Levels in Patients with Benign and Malignant Diseases: False-Positive Results Related to Liver and Renal Function

Rafael Molina, Javier Martínez Navarro, Xavier Filella et al. · Tumor Biology · 2002 · 71 citations